RIGHI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 2.866
EU - Europa 1.967
AS - Asia 1.261
AF - Africa 159
SA - Sud America 8
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.267
Nazione #
US - Stati Uniti d'America 2.850
GB - Regno Unito 543
CN - Cina 509
SE - Svezia 310
IT - Italia 288
SG - Singapore 272
VN - Vietnam 258
DE - Germania 256
IN - India 140
UA - Ucraina 108
IE - Irlanda 96
RU - Federazione Russa 82
FR - Francia 77
CH - Svizzera 53
ZA - Sudafrica 48
TG - Togo 47
EE - Estonia 38
CI - Costa d'Avorio 35
FI - Finlandia 27
BG - Bulgaria 26
NG - Nigeria 24
JO - Giordania 22
BE - Belgio 21
IR - Iran 19
CA - Canada 14
NL - Olanda 14
ID - Indonesia 8
TR - Turchia 6
GR - Grecia 5
LB - Libano 5
AU - Australia 4
BR - Brasile 4
HK - Hong Kong 4
HR - Croazia 4
CZ - Repubblica Ceca 3
LU - Lussemburgo 3
AM - Armenia 2
AT - Austria 2
CL - Cile 2
HU - Ungheria 2
JP - Giappone 2
LV - Lettonia 2
PK - Pakistan 2
PL - Polonia 2
PT - Portogallo 2
SC - Seychelles 2
TW - Taiwan 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
KR - Corea 1
KW - Kuwait 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 6.267
Città #
Southend 501
Fairfield 341
Chandler 278
Singapore 245
Ashburn 204
Wilmington 176
Woodbridge 173
Houston 170
Dong Ket 154
Seattle 149
Princeton 135
Ann Arbor 131
Cambridge 130
Dublin 96
Santa Clara 84
Bologna 80
Boardman 77
Nanjing 65
Westminster 53
Padova 51
Bern 50
New York 50
Lomé 47
Beijing 46
Jacksonville 39
Abidjan 35
Bremen 35
Hyderabad 35
Berlin 31
Jinan 30
Saint Petersburg 29
Nanchang 28
Shenyang 26
Sofia 26
Abeokuta 24
Helsinki 24
Hebei 23
Amman 22
Tianjin 22
Brussels 21
Jiaxing 19
Medford 18
Falls Church 17
Mülheim 17
San Diego 17
Guangzhou 15
Zhengzhou 15
Hangzhou 14
Taizhou 14
Changsha 13
Milan 13
Toronto 12
Los Angeles 11
Ningbo 11
San Venanzo 11
Haikou 10
Redmond 10
Turin 10
Redwood City 9
Shanghai 9
Fuzhou 8
Jakarta 8
Olalla 7
Rome 7
Taiyuan 7
Ardabil 6
Bühl 6
Leawood 6
Monmouth Junction 6
Boydton 5
Florence 5
Lanzhou 5
London 5
Norwalk 5
Phoenix 5
San Francisco 5
Trabia 5
Zanjan 5
Dearborn 4
Des Moines 4
Frankfurt Am Main 4
Istanbul 4
Kuban 4
Pune 4
Ravenna 4
San Mateo 4
Verona 4
Acton 3
Amsterdam 3
Cesena 3
Den Haag 3
Edinburgh 3
Fremont 3
Hong Kong 3
Kunming 3
Lappeenranta 3
Melbourne 3
Pesaro 3
Shenzhen 3
Shijiazhuang 3
Totale 4.382
Nome #
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 194
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 179
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 157
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 155
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 152
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified 152
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 146
IFI16 expression is related to selected transcription factors during B-cell differentiation 142
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 139
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma 136
BCL10 down-regulation in peripheral T-cell lymphomas. 136
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 133
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 132
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 132
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 130
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 130
Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall 127
SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis. 126
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 126
Pathobiology of hodgkin lymphoma. 126
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 123
Familial haemophagocytic lymphohistiocytosis-related plasma cell neoplasm: a case report. 121
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 121
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 118
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 115
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. 114
Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. 111
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 111
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 109
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 105
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 105
Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified. 105
Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. 104
Integrated molecular profilino for the diagnosis and classification of peripheral T-cell lymphomas. 104
Identification of Novel Cryptic Chromosomal Abnormalities in Primary Myelofibrosis by Single-Nucleotide Polymorphism Oligonucleotide Microarray. 104
Variable activation of canonical and alternative NF-Kappa B pathway in peripheral T-Cell Lymphoma not otherwise specified. 98
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis. 98
Use of IGK gene rearrangement analysis for clonality assesment of lymphoid malignancies. A single center experience. 95
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 93
Gene expression profiling of peripheral T-cell lymphoma: From bench to bedside 89
Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients 88
Intracellular TCR-signaling Pathway: Novel Markers for Lymphoma Diagnosis and Potential Therapeutic Targets 88
Detection of LMO2 in Normal Human Tissue and Haematopoietic and Non-Haematopoietic Tumours by a Newly Developed Rabbit Monoclonal Antibody. 87
P27 regulation in peripheral T-cell lymphoma not otherwise specified 86
Tissue micro-array in haematopathology:present usage and potential. 85
Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive 85
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. 84
Peripheral T-cell lymphoma. A still uncurable disease? 80
Expression of classical NF-kappa B pathway molecules in peripheral t-cell lymphoma not otherwise specified. 75
Proliferation centres in chronic lymphocytic leucemia: correlation with cytogenetic and clinicobiological features in 183 patients analyzed on tissue-microarrays. 72
null 68
PDGFRA activity deregulation in PTCL/NOS is a consequence of miRNA deregulation and autocrine loop sustainment. 65
LMO2 is a useful marker for the study and diagnosis of haematolymphoid neoplasms. 64
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified 62
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 55
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 45
Three-dimensional models: a novel approach for lymphoma research 44
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified (Modern Pathology, (2020), 33, 2, (179-187), 10.1038/s41379-019-0279-8) 35
Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation 34
Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence 31
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease 28
TOX Expression in Mycosis Fungoides and Sezary Syndrome 27
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial 25
The role of peritumoral CD8 + /TIA1 + lymphocytes in hepatocellular carcinoma aggressiveness and recurrence after surgical resection 23
The Medium Obtained from the Culture of Hodgkin Lymphoma Cells Affects the Biophysical Characteristics of a Fibroblast Cell Model 21
Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes 12
Correction to: Three-dimensional models: a novel approach for lymphoma research 10
Totale 6.472
Categoria #
all - tutte 17.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020863 0 0 0 0 0 0 181 183 188 105 76 130
2020/2021788 149 54 32 26 10 27 8 34 100 26 34 288
2021/20221.137 106 65 62 68 103 56 21 62 35 143 237 179
2022/20231.313 161 181 72 153 104 96 31 64 233 27 105 86
2023/2024427 21 67 39 35 35 99 26 25 17 40 12 11
2024/2025792 102 176 158 104 178 64 10 0 0 0 0 0
Totale 6.472